Skip to main content

PerkinElmer, Vivascience to Develop Protein Fractionation Kits for PerkinElmer Biomarker System

NEW YORK, Aug. 3 (GenomeWeb News) - PerkinElmer has signed onto a collaboration with Vivascience to create fractionation kits for proteomics-based biomarker analysis, the companies said today.


Under the agreement, the companies will combine PerkinElmer's elution chemistries with Vivascience's membrane adsorber chromatography technology to create the kits. PerkinElmer said it will then market these biomarker screening reagent kits along with its biomarker screening instruments, which include its Multiprobe II liquid handling workstation and proTOF 2000 MALDI-TOF mass spectrometer. The parties did not disclose the financial terms of the agreement.


PerkinElmer also said that Predictive Diagnostics, which recently began using PerkinElmer's proTOF for its clinical proteomics program, will have early access to the PerkinElmer/Vivascience fractionation kits through the end of the year.


Vivascience, of Hannover, Germany, produces chromatography technology that is rigid, unlike traditional resins and beads, the companies said.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.